As of Mar 23
| -11.76 / -4.33%|
The 30 analysts offering 12-month price forecasts for Biogen Inc have a median target of 393.50, with a high estimate of 430.00 and a low estimate of 289.00. The median estimate represents a +51.27% increase from the last price of 260.13.
The current consensus among 33 polled investment analysts is to Buy stock in Biogen Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.